|
|
|
|
|
|
|
January 2008 January 31, 2008 January 30, 2008 CHICAGO (Reuters) - The kidney cancer pill Nexavar, know generically as sorafenib, has shown promise in treating a small number of people with a type of blood cancer known as acute myeloid leukemia, or AML, U.S. researchers said on Tuesday. January 30, 2008 NEW YORK (Reuters Health) - Surgery for lung cancer can have a substantial impact on long-term, health-related quality of life, the results of a study published in the current issue of the Journal of Clinical Oncology suggest. January 29, 2008 Birth control pill lowers ovarian cancer risk - study January 25, 2008 LONDON (Reuters) - Birth control pills can protect women against ovarian cancer for 30 years or longer after they stop taking them and have so far prevented 100,000 ovarian cancer deaths worldwide, British researchers said on Thursday. January 23, 2008 PROVIDENCE, R.I. (Reuters) - Requiring even a small co-payment dramatically reduces the likelihood that women will get regular mammograms to detect breast cancer, researchers reported on Wednesday. January 22, 2008 LONDON (Reuters) - Bayer AG and Onyx Pharmaceutical Inc.'s key cancer drug Nexavar significantly raises the risk of high blood pressure, U.S. researchers said on Tuesday. January 22, 2008 NEW YORK (Reuters Health) - Cigarette smoking dramatically increases the risk that a woman who has undergone radiation treatment for breast cancer will develop lung cancer later on, a new study shows. January 22, 2008 NEW YORK (Reuters Health) - In men with prostate cancer, androgen-deprivation therapy (ADT) appears to increase the risk of subsequent diabetes, according to researchers. January 21, 2008 CHICAGO (Reuters) - More than one in 20 patients undergoing breast surgery later developed infections at incision sites, according to a study released on Monday, a complication that was more common than thought. January 15, 2008 NEW YORK (Reuters Health) - New research indicates that as little as 3 years of using combined estrogen and progestin menopausal hormone therapy (CHT) substantially increases the risk of developing lobular breast carcinoma. January 14, 2008 NEW YORK (Reuters Health) - The American College of Physicians released guidelines on Monday that focus on improving the recognition and palliative care of pain, dyspnea, and depression -- the most common symptoms seen with a serious illness at the end of life. January 10, 2008 BOSTON (Reuters) - The Wyeth drug Rapamune (sirolimus) dramatically reduces rare growths known as angiomyolipomas after one year of treatment, but the benefits begin to fade if the transplant drug is discontinued, researchers reported on Wednesday. January 10, 2008 WASHINGTON (Reuters) - Scientists in the United States are developing a screening test for breast cancer that checks a woman's saliva for evidence of the disease to help find tumors early, when they are most treatable. January 8, 2008 NEW YORK (Reuters Health) - Pooled data from numerous studies indicate that contrast-enhanced magnetic resonance (MR) imaging has a high specificity in detection of breast cancer in patients with breast lesions, Dutch researchers report in the January issue of Radiology. January 8, 2008 NEW YORK (Reuters Health) - In a large study of U.S. veterans, the use of a commonly prescribed class cholesterol-lowering drugs called "statins," which include drugs such as Lipitor, reduced the cancer rate by about 25 percent. January 8, 2008 NEW YORK (Reuters Health) - New research indicates there is considerable variation in the risk of breast cancer among carriers of BRCA1/2 mutations, which are known to increase the risk of breast cancer. January 7, 2008 WASHINGTON (Reuters) - U.S. blacks continue to get inferior cancer treatment compared with whites, researchers reported Monday in a study showing that disparities first documented in the early 1990s persist despite efforts to erase them. January 3, 2008 NEW YORK (Reuters Health) - Radiofrequency ablation (RFA) of small hepatocellular carcinoma (HCC) is as effective when delivered percutaneously as with a surgical approach, but with lower morbidity, according to a report in the December issue of the Archives of Surgery. January 3, 2008 NEW YORK (Reuters Health) - Anthracycline-based adjuvant chemotherapy for early breast cancer improves overall and disease-free survival only in women whose breast tumors overexpress or amplify HER2, results of a meta-analysis indicate. January 3, 2008 NEW YORK (Reuters Health) - A meta-analysis of trial data indicates that adjuvant chemotherapy regimens used in the 1970s and 1980s safely improved the long-term survival of estrogen receptor (ER)-poor breast cancer. The authors believe that current and future chemotherapy regimens are likely to yield even greater improvements in survival. January 2, 2008 NEW YORK (Reuters Health) - In children with non-CNS malignancies, fluorodeoxyglucose (FDG) PET combined with CT in a single examination shows significantly better diagnostic performance than does conventional imaging, such as contrast CT or MRI, researchers report in the December issue of the Journal of Nuclear Medicine. January 2, 2008 NEW YORK (Reuters Health) - New research suggests that the use of androgen deprivation therapy (ADT) for 2 months before and during external beam radiotherapy (EBRT) can help slow the growth of locally advanced prostate cancer. Moreover, this short course of ADT does not increase the risk of fatal cardiac events. January 2, 2008 NEW YORK (Reuters Health) - Cancer patients often refuse opioid medications out of the belief that the drugs are offered as a "last resort" rather than as legitimate pain killers that can improve their quality of life, British investigators report. January 2, 2008 NEW YORK (Reuters Health) - Radiotherapy is appropriate for most patients with primary cutaneous B-cell lymphomas (CBCL), according to a recent Dutch study, but more aggressive treatment is needed in patients presenting with lesions on the leg. Copyright 2008 Reuters. Click for Restrictions.
|
